Theliatinib tartrate - CAS 2413487-72-4

Theliatinib (Xiliertinib) tartrate is a potent and highly selective EGFR inhibitor with ATP-competitive and orally active properties, showing a K_i of 0.05 nM and an IC_50 of 3 nM for EGFR, and an IC_50 of 22 nM for the EGFR T790M/L858R mutant, with over 50-fold selectivity for EGFR compared to other kinases.

Others, EGFR

JAK/STAT signaling, Others, Angiogenesis, Tyrosine Kinase/Adaptors

2413411

C29H32N6O8

592.6

[C@@H]([C@H](C(O)=O)O)(C(O)=O)O.N(C=1C2=C(C=C(OC)C(NC(=O)N3C[C@]4([C@@](C3)(CCN4C)[H])[H])=C2)N=CN1)C5=CC(C#C)=CC=C5

-20°C

Ice Packs

Small Compound